ADVISORY/Biochips: The Future of Medical Research.Business Editors ADVISORY... --(BUSINESS WIRE)--Dec. 21, 1999 TOPIC: Test tubes and petri dishes may soon be replaced by "biochips," a new development in medical research. Biochips are integrated-circuits which contain genetic material, and represent a major advance in the biotechnology industry, according to The New York Times. The devices, also known as microarrays, resemble high-tech semiconductor chips, but hold DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. . By inserting the chips into analytical devices, scientists can perform genetic experiments quickly at a relatively low cost. The development of biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of tools reportedly has been heralded as a watershed in genetic research. Biochips are used to pinpoint genetic predisposition to diseases and adverse drug reactions, and also to develop customized therapy for individual disorders. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story: Dr. Mitch Eggers Eggers may refer to:
Dr. Christopher Aston, a professor from New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the currently working at Wyeth Ayerst Research, has 10 years of experience as a scientist in the biomedical field and most recently in the field of genomics. He is familiar with the work of key players in the biological and biotechnology arena. 732-274-4344 aston@med.nyu.edu Dr. Kerry Lowrie, manager of marketing at Display Systems Biotech, is an expert in bioinformatics, gene arrays and genomics technology platforms for pharmaceutical customers. 760-599-0598 kerryl@displaysys.com Professor Howard Robert Horvitz of Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, studies genetics and neurogenetics neu·ro·ge·net·ics n. The study of genetic factors that contribute to development of neurological disorders. . 617-253-4671 617-253-1000 ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue. ExpertSource, a collaboration of Business Wire and The Round Table Group, provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at the above web address. Business Wire's Media Resource Center provides working journalists many free media services. Please visit the BW Media Resource Center at (www.businesswire.com/media) for more information. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion